Let’s take a look at who’s green in the cannabis penny stocks market today! Things look like they could be turning around for the better.
Cannabis Penny Stocks in Green
First up is one of the biggest gainers for today, Isodiol International Inc. (CSE:ISOL), which is currently up over 25% and selling for $2.03 CAD at the time of writing.
The company is primarily focused on the development of CBD-based pharmaceuticals and consumer products.
Only two days ago, it added Franco Columbu to its management team at Iso-Sport. Mr. Columbu is a former champion bodybuilder and World’s Strongest Man competitor. His position will see him develop the business-side of Iso-Sport. He will raise further awareness of the company’s health and wellness CBD products for athletes around the world.
Could his addition to the team be the reason for this stock hike? With 191 thousand Instagram followers, he might just be.
Cannabis Penny Stocks: VIVO Cannabis
VIVO Cannabis (TSXV:VIVO) is an Ontario-based company. Recognized for high-quality cannabis products and services, it holds production and sales licenses from Health Canada and operates indoor cultivation facilities with proprietary plant-growing technology.
Vivo is in the green today, up 3.96% and selling for $1.05 at the time of writing.
It could be because its wholly-owned subsidiary, Harvest Medicine Inc. is launching a free telemedicine service for medical cannabis care and education with a new app. The service, called HMED Connect, will allow patients from across Canada to access Harvest Medicine’s education and patient-centric model via their phones or desktops.
Cannabis Penny Stocks: Terra Tech Corp.
Terra Tech (OTCQX:TRTC) is in the green today, most likely because of a $5 million investment in Hydrofarm Holdings Group Inc.
Terra is an integrated cannabis-focused agriculture company. With this investment, the company plans to take an ownership stake in “the longest standing specialty indoor garden wholesaler in the US.”
Hydrofarm sounds like a positive investment for Terra. Not only has the market reacted well to the news—stock is up 3.27%, selling for $1.74—Hydrofarm recorded over $250 million in revenues in 2017.
Featured Image: Depositphotos/© Yurich84